Please use this identifier to cite or link to this item:
https://doi.org/10.1152/ajpendo.00480.2020
DC Field | Value | |
---|---|---|
dc.title | COVID-19 endocrinopathy with hindsight from SARS | |
dc.contributor.author | Kothandaraman, Narasimhan | |
dc.contributor.author | Rengaraj, Anantharaj | |
dc.contributor.author | Xue, Bo | |
dc.contributor.author | Yew, Wen Shan | |
dc.contributor.author | Velan, S Sendhil | |
dc.contributor.author | Karnani, Neerja | |
dc.contributor.author | Leow, Melvin Khee Shing | |
dc.date.accessioned | 2023-03-23T00:29:03Z | |
dc.date.available | 2023-03-23T00:29:03Z | |
dc.date.issued | 2021-01-01 | |
dc.identifier.citation | Kothandaraman, Narasimhan, Rengaraj, Anantharaj, Xue, Bo, Yew, Wen Shan, Velan, S Sendhil, Karnani, Neerja, Leow, Melvin Khee Shing (2021-01-01). COVID-19 endocrinopathy with hindsight from SARS. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 320 (1) : 139-149. ScholarBank@NUS Repository. https://doi.org/10.1152/ajpendo.00480.2020 | |
dc.identifier.issn | 0193-1849 | |
dc.identifier.issn | 1522-1555 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/238320 | |
dc.description.abstract | Context: The current COVID-19 pandemic is probably the worst the world has ever faced since the start of the new millennium. While the respiratory system is the most prominent target of SARS-CoV-2 (the contagion of COVID-19), extra-pulmonary involvement are emerging as important contributors of its morbidity and lethality. This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We hereby summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone and reproductive system aberrations so that clinicians armed with such insights can potentially benefit COVID-19 patients at the bedside. | |
dc.language.iso | en | |
dc.publisher | AMER PHYSIOLOGICAL SOC | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Endocrinology & Metabolism | |
dc.subject | Physiology | |
dc.subject | COVID-19 | |
dc.subject | endocrine system | |
dc.subject | SARS | |
dc.subject | SARS-CoV-2 | |
dc.subject | virus | |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | |
dc.subject | MAS RECEPTOR | |
dc.subject | MERS-COV | |
dc.subject | CORONAVIRUS | |
dc.subject | SPIKE | |
dc.subject | PROTEIN | |
dc.subject | SARS-COV-2 | |
dc.subject | INFECTION | |
dc.subject | ANGIOTENSIN-(1-7) | |
dc.subject | EXPRESSION | |
dc.type | Review | |
dc.date.updated | 2023-03-22T08:44:04Z | |
dc.contributor.department | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | OBSTETRICS & GYNAECOLOGY | |
dc.description.doi | 10.1152/ajpendo.00480.2020 | |
dc.description.sourcetitle | AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | |
dc.description.volume | 320 | |
dc.description.issue | 1 | |
dc.description.page | 139-149 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
ajpendo.00480.2020.pdf | Published version | 1.57 MB | Adobe PDF | CLOSED | Published |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.